The World Health Organization (WHO) classifies DLBCL with MYC and BCL2 rearrangements and the simultaneous occurrence of BCL6 gene rearrangement as double-hit lymphoma (DHL) or triple-hit lymphoma (THL). The gene discussed is BCL2; the disease is lymphoma.